Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cysteamine Therapy in NASH
NCT00799578Phase 2Completed
- Sponsor
- Joel Lavine
- Start
- Oct 2008
- Primary completion
- Jun 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cysteamine in Nonalcoholic steatohepatitis (NASH), sponsored by Joel Lavine. Started Oct 2008; status: completed.
02
Drugs
cysteamine
03
Conditions
Nonalcoholic steatohepatitis (NASH)
Beyond the preview
Go deeper on NCT00799578.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00799578.